Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 12, 2025 04:01 ET | Source: Research and Markets

2 Day Virtual FDA (Food and Drug Administration) Drug Approval Process Training Course (Feb 23rd - Feb 24th, 2026)

Dublin, Dec. 12, 2025 (GLOBE NEWSWIRE) -- The "The FDA (Food and Drug Administration) Drug Approval Process Training Course (Feb 23rd - Feb 24th, 2026)" training has been added to ...
December 10, 2025 16:30 ET | Source: Serina Therapeutics, Inc.

Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program

– Company addresses FDA requests regarding formulation excipient – Global site start-up activities continue, with first-patient-in for registrational Phase 1b study targeted for Q1 2026, subject to...
July 30, 2025 07:40 ET | Source: Research and Markets

2 Day FDA (Food and Drug Administration) Drug Approval Process Training Course | Stay Ahead with Insights into IND, NDA, ANDA, and 505(b)(2) Submissions (ONLINE EVENT: October 7-8, 2025)

Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "The FDA (Food and Drug Administration) Drug Approval Process Training Course" training has been added to ResearchAndMarkets.com's offering. The US...
May 12, 2025 09:00 ET | Source: BIOXYTRAN, INC.

Bioxytran Completes Dose Optimization of Antiviral, ProLectin-M

BOSTON, MASSACHUSETTS, May 12, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing novel antiviral therapies, today announced...
March 26, 2025 03:00 ET | Source: Pleco Therapeutics B.V.

Pleco Therapeutics Announces Positive Outcome of Pre-IND meeting with FDA for PTX-252 in Acute Myeloid Leukaemia

Pleco Therapeutics announces positive FDA feedback on PTX-252, supporting IND pathway for its novel AML treatment.
February 06, 2025 12:43 ET | Source: Research and Markets

The FDA (Food and Drug Administration) Drug Approval Process Online Training Course (June 11-12, 2025): Essential Strategies for INDs, NDAs, ANDAs, and 505(b)(2) Applications

Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The "The FDA (Food and Drug Administration) Drug Approval Process Training Course" conference has been added to ResearchAndMarkets.com's offering. The US...
January 30, 2025 07:54 ET | Source: Research and Markets

FDA (Food and Drug Administration) Drug Approval Process Training Course: Practical Insights into FDA Requirements and Up to Date Developments (ONLINE EVENT: February 24-25, 2025)

Dublin, Jan. 30, 2025 (GLOBE NEWSWIRE) -- The "The FDA (Food and Drug Administration) Drug Approval Process Training Course" has been added to ResearchAndMarkets.com's offering. The US is the...
November 21, 2024 06:08 ET | Source: Research and Markets

FDA (Food and Drug Administration) Drug Approval Process Training Course: Comprehensive Programme Covering Procedures for Submission of INDs, NDAs, ANDAs and 505(b)(2) (LIVE ONLINE EVENT/ON-DEMAND)

Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "The FDA (Food and Drug Administration) Drug Approval Process Training Course" conference has been added to ResearchAndMarkets.com's offering. The US...
April 02, 2024 07:49 ET | Source: Research and Markets

Drug Discovery and Early Development Outsourcing Services - Growth Opportunities in De Novo Drug Design and Disease Modeling with Generative AI

Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "Growth Opportunities in Drug Discovery and Early Development Outsourcing Services" report has been added to ResearchAndMarkets.com's offering. The...
January 22, 2024 11:43 ET | Source: Research and Markets

The FDA (Food and Drug Administration) Drug Approval Process, 2 Day Virtual Training Course

Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "The FDA (Food and Drug Administration) Drug Approval Process Training Course" has been added to ResearchAndMarkets.com's offering. The US is the...